Under-reporting in UK prompts MHRA to issue alert
This article was originally published in SRA
Faced with a further reduction in the number of medical device-related adverse incidents being reported by healthcare professionals in the UK, the Medicines and Healthcare products Regulatory Agency has warned senior National Health Service managers that under-reporting can lead to serious safety issues not being identified and prevent the agency pursuing corrective action with manufacturers.
You may also be interested in...
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.